buagafuran capsule
/ Beijing Union Pharmaceutical Factory
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
February 16, 2024
BGFN-2022-01: Phase Ⅲ Clinical Trial of Buagafuran Capsules in the Treatment of GAD
(clinicaltrials.gov)
- P3 | N=410 | Recruiting | Sponsor: Beijing Union Pharmaceutical Factory Ltd
New P3 trial • CNS Disorders • General Anxiety Disorder • Mood Disorders • Psychiatry
February 16, 2024
BGFN-2022-02: Phase 3 Clinical Trial of Buagafuran Capsules in the Treatment of GAD
(clinicaltrials.gov)
- P3 | N=504 | Recruiting | Sponsor: Beijing Union Pharmaceutical Factory Ltd
New P3 trial • CNS Disorders • General Anxiety Disorder • Mood Disorders • Psychiatry
1 to 2
Of
2
Go to page
1